Insight Molecular Diagnostics Inc.
IMDX- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001642380
No open-market purchases or sales by Insight Molecular Diagnostics Inc. insiders were filed in the last 90 days; 43 institutions reported holding it in 13F filings for Q3 2026, worth $66.6M in total; no superinvestor holds it.
Holders of 5% or more of IMDX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Insight Molecular Diagnostics Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Broadwood Partners, L.P. | 13D/A | 39.70%12.8M shares | +2.30 ppfrom 37.40% | Jan 22, 202110 filings | Apr 27, 2026 | SEC |
| Smith Patrick W | 13G/A | 10.50%1.77M shares | – | Oct 9, 20243 filings | Dec 27, 2024 | SEC |
| AWM Investment Company, Inc. | 13G/A | 10.00%2.86M shares | +2.50 ppfrom 7.50% | Feb 14, 20234 filings | May 9, 2025 | SEC |
| Bio-Rad Laboratories, Inc. | 13G/A | 9.70%2.76M shares | – | Apr 22, 20243 filings | Mar 4, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
33 Schedule 13D and 13G filings on Insight Molecular Diagnostics Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Apr 27, 20267:14 PM ET | Broadwood Partners, L.P.and 2 others | 13D/A | 39.70%12.8M shares | +2.30 ppfrom 37.40% | Apr 23, 2026 | SEC |
| Feb 12, 20267:52 PM ET | Broadwood Partners, L.P.and 2 others | 13D/A | 37.40%12.1M shares | −2.80 ppfrom 40.20% | Feb 10, 2026 | SEC |
| May 9, 20254:06 PM ET | AWM Investment Company, Inc. | 13G/A | 10.00%2.86M shares | +2.50 ppfrom 7.50% | Mar 31, 2025 | SEC |
| Mar 4, 20257:06 PM ET | Bio-Rad Laboratories, Inc. | 13G/A | 9.70%2.76M shares | – | Feb 10, 2025 | SEC |
| Feb 14, 20252:41 PM ET | AWM Investment Company, Inc. | 13G/A | 7.50%1.31M shares | – | Dec 31, 2024 | SEC |
| Feb 10, 20258:46 PM ET | Broadwood Partners, L.P.and 2 others | 13D/A | 40.20%11.6M shares | – | Feb 6, 2025 | SEC |
| Dec 27, 20249:58 PM ET | Smith Patrick Wand 1 other | 13G/A | 10.50%1.77M shares | – | Dec 26, 2024 | SEC |
| Dec 9, 2024 | Smith Patrick W | 13G/AOld format | – | – | – | SEC |
| Nov 14, 2024 | Pura Vida Investments, LLC | 13GOld format | – | – | – | SEC |
| Oct 24, 2024 | Bio-Rad Laboratories, Inc. | 13G/AOld format | – | – | – | SEC |
| Oct 9, 2024 | Smith Patrick W | 13GOld format | – | New | – | SEC |
| Apr 22, 2024 | Bio-Rad Laboratories, Inc. | 13GOld format | – | New | – | SEC |
| Apr 15, 2024 | Broadwood Partners, L.P. | 13D/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Pura Vida Investments, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | AWM Investment Company, Inc. | 13G/AOld format | – | – | – | SEC |
| Apr 14, 2023 | Pura Vida Investments, LLC | 13G/AOld format | – | – | – | SEC |
| Apr 7, 2023 | Broadwood Partners, L.P. | 13D/AOld format | – | – | – | SEC |
| Feb 14, 2023 | Pura Vida Investments, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2023 | Pura Vida Investments, LLC | 13GOld format | – | – | – | SEC |
| Feb 14, 2023 | AWM Investment Company, Inc. | 13GOld format | – | New | – | SEC |
| Nov 25, 2022 | Norfield Capital LLC | 13GOld format | – | New | – | SEC |
| Jul 28, 2022 | Broadwood Partners, L.P. | 13D/AOld format | – | – | – | SEC |
| May 9, 20223:23 PM ET | BlackRock Inc. | 13GOld format | – | – | – | SEC |
| Apr 18, 2022 | Halle Special Situations Fund LLC | 13GOld format | – | New | – | SEC |
| Apr 15, 2022 | Broadwood Partners, L.P. | 13D/AOld format | – | – | – | SEC |
| Feb 4, 20224:12 PM ET | BlackRock Inc. | 13GOld format | – | – | – | SEC |
| Sep 24, 2021 | Broadwood Partners, L.P. | 13D/AOld format | – | – | – | SEC |
| Feb 10, 20213:04 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2021 | Broadwood Partners, L.P. | 13D/AOld format | – | – | – | SEC |
| Feb 2, 20213:13 PM ET | BlackRock Inc. | 13GOld format | – | New | – | SEC |
| Jan 28, 2021 | Pura Vida Investments, LLC | 13G/AOld format | – | – | – | SEC |
| Jan 22, 2021 | Broadwood Partners, L.P. | 13D/AOld format | – | – | – | SEC |
| Jan 8, 20215:00 PM ET | Lineage Cell Therapeutics, Inc. | 13D/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Insight Molecular Diagnostics Inc. shares.
No Form 144 notices for Insight Molecular Diagnostics Inc. are on file.